Minerva Neurosciences NERV
NASDAQ NERV
$3.35 -0.05 (-1.47%)
At close: Sep 29, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) EV to EBIT (2020 - 2021)

Updated

Minerva Neurosciences' EV to EBIT came in at 6.75 for Q1 2021, down 83.3% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) EV to EBIT (2020 - 2021) Analysis & Trends

Over the trailing twelve months to Mar 31, 2021, Minerva Neurosciences reported EV to EBIT of -7.34; for FY2020, it came in at 40.40.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Minerva Neurosciences 160.57 Mn 160.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 6.75
Dec 31, 2020 40.39
API Access

Minerva Neurosciences EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=NERV&period=max&api_key=YOUR_API_KEY